Screening mammography for women 40 to 49 years of age: A clinical practice guideline from the American College of Physicians

被引：103

作者：

Qaseem, Amir

Snow, Vincenza

Sherif, Katherine

Aronson, Mark

Weiss, Kevin B.

Owens, Douglas K.

机构：

[1] Amer Coll Physicians, Philadelphia, PA 19106 USA

[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA

[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[4] Northwestern Univ, Chicago, IL 60611 USA

[5] Vet Affairs Edward Hines Jr Hosp, Chicago, IL USA

[6] Stanford Univ, Stanford, CA 94305 USA

[7] Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA

来源：

ANNALS OF INTERNAL MEDICINE | 2007年 / 146卷 / 07期

关键词：

D O I：

10.7326/0003-4819-146-7-200704030-00007

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

Breast cancer is one of the most common causes of death for women in their 40s in the United States. Individualized risk assessment plays an important role when making decisions about screening mammography, especially for women 49 years of age or younger. The purpose of this guideline is to present the available evidence for screening mammography in women 40 to 49 years of age and to increase clinicians' understanding of the benefits and risks of screening mammography.

引用

页码：511 / 515

页数：5

共 31 条

[1]

(ACOG) American College of Obstetricians and Gynecologists, 2003, Obstet Gynecol, V101, P821

[2]

American Cancer Society, 2005, CANC FACTS FIG 2005

[3]

Assessing the risk of breast cancer. [J].

Armstrong, K ;

Eisen, A ;

Weber, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) :564-571

[4]

Screening mammography in women 40 to 49 years of age: A systematic review for the American College of Physicians [J].

Armstrong, Katrina ;

Moye, Elizabeth ;

Williams, Sankey ;

Berlin, Jesse A. ;

Reynolds, Eileen E. .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (07) :516-526

[5]

Bakker D A, 1998, Oncol Nurs Forum, V25, P115

[6]

Trends in the treatment of ductal carcinoma in situ of the breast [J].

Baxter, NN ;

Virnig, BA ;

Durham, SB ;

Tuttle, TM .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (06) :443-448

[7]

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility:: Recommendation statement [J].

Berg, AO ;

Allan, JD ;

Calonge, N ;

Frame, PS ;

Gordis, L ;

Gregory, KD ;

Harris, R ;

Johnson, MS ;

Klein, JD ;

Loveland-Cherry, C ;

Moyer, VA ;

Ockene, JK ;

Petitti, DB ;

Siu, AL ;

Teutsch, SM ;

Yawn, BP .

ANNALS OF INTERNAL MEDICINE, 2005, 143 (05) :355-361

[8]

Screening for breast cancer: Recommendations and rationale [J].

Berg, AO ;

Allan, JD ;

Frame, PS ;

Homer, CJ ;

Johnson, MS ;

Klein, JD ;

Lieu, TA ;

Mulrow, CD ;

Orleans, CT ;

Peipert, JF ;

Pender, NJ ;

Siu, AL ;

Teutsch, SM ;

Westhoff, C ;

Woolf, SH .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (05) :344-346

[9]

Effect of screening and adjuvant therapy on mortality from breast cancer [J].

Berry, DA ;

Cronin, KA ;

Plevritis, SK ;

Fryback, DG ;

Clarke, L ;

Zelen, M ;

Mandelblatt, JS ;

Yakovlev, AY ;

Habbema, JDF ;

Feuer, EJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792

[10]

BREW M D, 1989, Australasian Radiology, V33, P335, DOI 10.1111/j.1440-1673.1989.tb03306.x

← 1 2 3 4 →